vs
Side-by-side financial comparison of BYLINE BANCORP, INC. (BY) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
BYLINE BANCORP, INC. is the larger business by last-quarter revenue ($112.4M vs $61.6M, roughly 1.8× ORTHOPEDIATRICS CORP). BYLINE BANCORP, INC. runs the higher net margin — 33.4% vs -16.4%, a 49.8% gap on every dollar of revenue. On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs 9.0%). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs 6.4%).
Byline Bank is a bank headquartered in Chicago, Illinois, United States. It is the primary subsidiary of Byline Bancorp, Inc., a bank holding company, and the 4th largest SBA 7(a) lender.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
BY vs KIDS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $112.4M | $61.6M |
| Net Profit | $37.6M | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | — | -13.3% |
| Net Margin | 33.4% | -16.4% |
| Revenue YoY | 9.0% | 17.0% |
| Net Profit YoY | 33.0% | 37.1% |
| EPS (diluted) | $0.83 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $61.6M | ||
| Q3 25 | $115.7M | $61.3M | ||
| Q2 25 | $110.5M | $61.1M | ||
| Q1 25 | $103.1M | $52.4M | ||
| Q4 24 | $104.7M | $52.7M | ||
| Q3 24 | $101.8M | $54.6M | ||
| Q2 24 | $99.4M | $52.8M |
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $-10.1M | ||
| Q3 25 | $37.2M | $-11.8M | ||
| Q2 25 | $30.1M | $-7.1M | ||
| Q1 25 | $28.2M | $-10.7M | ||
| Q4 24 | $30.3M | $-16.1M | ||
| Q3 24 | $30.3M | $-7.9M | ||
| Q2 24 | $29.7M | $-6.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% |
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | -13.3% | ||
| Q3 25 | 43.1% | -15.4% | ||
| Q2 25 | 35.2% | -17.4% | ||
| Q1 25 | 36.4% | -21.0% | ||
| Q4 24 | 38.6% | -26.7% | ||
| Q3 24 | 39.3% | -10.2% | ||
| Q2 24 | 40.4% | -10.7% |
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | -16.4% | ||
| Q3 25 | 32.1% | -19.2% | ||
| Q2 25 | 27.2% | -11.6% | ||
| Q1 25 | 27.4% | -20.3% | ||
| Q4 24 | 34.3% | -30.5% | ||
| Q3 24 | 29.8% | -14.5% | ||
| Q2 24 | 29.9% | -11.4% |
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | $-0.43 | ||
| Q3 25 | $0.82 | $-0.50 | ||
| Q2 25 | $0.66 | $-0.30 | ||
| Q1 25 | $0.64 | $-0.46 | ||
| Q4 24 | $0.68 | $-0.70 | ||
| Q3 24 | $0.69 | $-0.34 | ||
| Q2 24 | $0.68 | $-0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.4M | $60.9M |
| Total DebtLower is stronger | — | $106.0M |
| Stockholders' EquityBook value | $1.3B | $346.6M |
| Total Assets | $9.9B | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $60.9M | ||
| Q3 25 | $259.0M | $57.7M | ||
| Q2 25 | $218.3M | $70.1M | ||
| Q1 25 | $421.3M | $58.8M | ||
| Q4 24 | $563.1M | $68.8M | ||
| Q3 24 | $452.6M | $76.1M | ||
| Q2 24 | $730.5M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $346.6M | ||
| Q3 25 | $1.2B | $349.3M | ||
| Q2 25 | $1.2B | $355.5M | ||
| Q1 25 | $1.1B | $347.1M | ||
| Q4 24 | $1.1B | $354.6M | ||
| Q3 24 | $1.1B | $370.9M | ||
| Q2 24 | $1.0B | $371.3M |
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $508.6M | ||
| Q3 25 | $9.8B | $493.5M | ||
| Q2 25 | $9.7B | $503.6M | ||
| Q1 25 | $9.6B | $470.3M | ||
| Q4 24 | $9.5B | $473.2M | ||
| Q3 24 | $9.4B | $489.3M | ||
| Q2 24 | $9.6B | $430.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $10.3M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 15.8% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $10.3M | ||
| Q3 25 | $38.3M | $-581.0K | ||
| Q2 25 | $16.3M | $-10.5M | ||
| Q1 25 | $27.1M | $-4.2M | ||
| Q4 24 | $175.2M | $-4.0M | ||
| Q3 24 | $19.8M | $-10.3M | ||
| Q2 24 | $40.1M | $-6.1M |
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $9.7M | ||
| Q3 25 | $38.0M | $-3.4M | ||
| Q2 25 | $15.2M | $-13.9M | ||
| Q1 25 | $25.0M | $-8.4M | ||
| Q4 24 | $171.2M | $-4.2M | ||
| Q3 24 | $19.1M | $-11.7M | ||
| Q2 24 | $39.4M | $-12.8M |
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 15.8% | ||
| Q3 25 | 32.8% | -5.6% | ||
| Q2 25 | 13.7% | -22.8% | ||
| Q1 25 | 24.3% | -16.0% | ||
| Q4 24 | 163.5% | -8.1% | ||
| Q3 24 | 18.8% | -21.4% | ||
| Q2 24 | 39.7% | -24.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 1.0% | ||
| Q3 25 | 0.3% | 4.6% | ||
| Q2 25 | 1.0% | 5.6% | ||
| Q1 25 | 2.0% | 8.1% | ||
| Q4 24 | 3.8% | 0.5% | ||
| Q3 24 | 0.6% | 2.5% | ||
| Q2 24 | 0.7% | 12.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | 5.78× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 1.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
